Search CGC
Canopy Growth Corp
Nasdaq · CIK 1737927
Last close0.88
Daily change-0.01 (-0.79%)
10 Years gain-97.29%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
CGC · STANDARD
SIC 2833 · Medicinal Chemicals & Botanical Products · Fiscal year end 0331
Fundamental
43.9Momentum
46.7Acceleration
43.4Confidence
85.0Annual Revenue10
Quarterly Revenue34
Annual CFO9
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth1.7 / 25
Quality18.7 / 25
Capital Efficiency7.5 / 20
Balance Sheet13.9 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Net debt reductionNet debt declined versus the comparison period.
Warnings
Receivables anomaly · MEDIUMAccounts receivable growth is materially above revenue growth.
ROIC declining · MEDIUMROIC declined by 2.341 percentage points.
Key Metrics
Revenue Growth TTM2.98%OK
Revenue CAGR 3Y-5.12%OK
Gross Margin29.33%OK
Operating Margin-30.88%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-11.51%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Yn/aINSUFFICIENT_HISTORY
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 FY Mar 31, 2026 | $284.60M | $69.67M | -$161.66M | -$63.81M | -$69.14M | 24.48% | -56.8% | -24.29% | -20.98% | 298.04M |
| 2026 FY Mar 31, 2025 | $269.00M | $79.51M | -$117.14M | -$165.75M | -$176.56M | 29.56% | -43.55% | -65.64% | -12.81% | 107.55M |
| 2026 FY Mar 31, 2024 | $297.15M | $80.88M | -$228.71M | -$281.95M | -$285.40M | 27.22% | -76.97% | -96.05% | -17.32% | 74.79M |
| 2025 FY Mar 31, 2023 | $333.25M | -$63.53M | -$2.63B | -$557.55M | -$566.66M | -19.06% | -789.34% | -170.04% | -83.04% | 46.37M |
| 2024 FY Mar 31, 2022 | $475.70M | -$187.41M | -$1.02B | -$545.81M | -$582.50M | -39.4% | -214.17% | -122.45% | -24.85% | 39.13M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $296.93M | sum latest 4 fiscal quarters Revenue | OK | 0001193125-25-270960, 0001193125-26-339076 |
| Revenue Growth TTM | 2.98% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001193125-25-270960, 0001193125-26-339076 |
| Revenue CAGR 3Y | -5.12% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001193125-26-270260 |
| Revenue CAGR 5Y | -12.24% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001193125-26-270260 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001193125-26-270260 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001193125-25-270960, 0001193125-26-339076 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 29.33% | Gross Profit / Revenue | OK | 0001193125-25-270960, 0001193125-26-339076 |
| Operating Margin | -30.88% | Operating Income / Revenue | OK | 0001193125-25-270960, 0001193125-26-339076 |
| ROIC | -11.51% | NOPAT / Average Invested Capital | OK | 0001193125-25-270960, 0001193125-26-339076 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001193125-26-339076 |
| Current Ratio | 3.04x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 1.4x | (Cash + Short-term Investments) / Total Debt | OK | 0001193125-26-339076 |
| Revenue per Diluted Share | $0.70 | Revenue / Diluted Shares | OK | 0001193125-25-270960, 0001193125-26-339076 |